Bayer shifts consumer care unit.
MORRISTOWN, N.J. -- Bayer AG has transferred the global headquarters of its Consumer Care Business Group here from Germany.
With the move Gary Balkema, head of the company's North America region, succeeded Frank Morich as general manager of the group. Morich was appointed to Bayer's board of management.
The consumer care group produces and markets over-the-counter medications, including Bayer aspirin and Alka-Seltzer and the household insecticides Autan and Baygon.
North America is the fastest-growing region for the O-T-C sector. The region, which includes the United States, Canada, Mexico and Central America, accounts for some 50% of the consumer care group's total sales. All together the group employs 5,300 people, approximately 2,000 of whom are already based in the North America region.
Consumer Care is the second Bayer business group to be headquartered in the U.S. Bayer Diagnostics, which is based in Tarrytown, N.Y., operates the company's global business in diagnostic equipment and reagents.
The changeover at the helm of Consumer Care means that the three business groups in Bayer's health care business segment are now managed by an international team.
Balkema, an American, joins David Ebsworth from the United Kingdom, who heads the Pharmaceuticals Business Group, and Rolf Classon, the Swedish general manager of the Diagnostics Business Group.
|Printer friendly Cite/link Email Feedback|
|Publication:||Chain Drug Review|
|Article Type:||Brief Article|
|Date:||May 22, 2000|
|Previous Article:||Griffin in line to become NACDS chairman in 2002.|
|Next Article:||Dutch firm to buy Rexall Sundown.|